Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Current Leases (2022 - 2026)

Updated

Adlai Nortye's Current Leases was $969,000 in Q2 2026, up 277.0% from $257,000 a year earlier.

Analysis

Adlai Nortye (ANL) Current Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, Current Leases at Adlai Nortye came in at $1.13 million, up 165.2% from FY2024.

  • Current Leases shows a three-year compound annual growth rate of -3.0% (FY2022 to FY2025).
  • In earlier years, Current Leases was $425,000 in FY2024 (-9.4%), $469,000 in FY2023 (-62.1%) and $1.24 million in FY2022.
  • Quarterly Current Leases has moved between $257,000 (Q2 2025) and $1.24 million (Q4 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Adlai Nortye 528.79 Mn 429.49 Mn - 969,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 969,000.00
Dec 31, 2025 1.13 Mn
Jun 30, 2025 257,000.00
Dec 31, 2024 425,000.00
Dec 31, 2023 469,000.00
Dec 31, 2022 1.24 Mn
API Access

Adlai Nortye Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ANL&period=max&api_key=YOUR_API_KEY